Consult this page regularly for the most recent information and updates on REB processes and approvals during the publicly declared emergency due to COVID-19.
The Research Ethics Office at 250 Yonge is not accepting hard copy submissions at this time. All submissions should sent to the REB Inbox (firstname.lastname@example.org).
COVID-19 Related Research:
All other studies:
At the present time, Unity Health is allowing on-site and in-person research activites are with limits on capacity and location. For more information and details on permissible research activities, please consult the research microsite.
The microsite also has information on requesting essential or essential plus status for studies that meet the criteria (see below) but have not requested it to date (either through CR3C or through Research Leadership in March 2020).
COVID Research Evalulation Committee (CREC) and Clinical Research Restart Committee (CR3C) reviews have been eliminated and separate approval from this committees for, respectively, COVID research and onsite research is no longer required.
About: Use the Planned Protocol Deviation form to notify the REB of temporary changes to approved study procedures as a result of a publicly declared emergency. NOTE: Temporary stoppage of recruitment or of your study due to the publicly declared emergency do not require planned protocol deviation notification; please do not submit these. If your study or recruitment is being stopped for other reasons (safety, efficacy, etc.), please report this to the REB as you normally would.
Process: The planned protocol deviation form consists of two parts.
Research Ethics Office (REO) Review of Part 1: